BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23109063)

  • 1. Diagnosis of Barth syndrome using a novel LC-MS/MS method for leukocyte cardiolipin analysis.
    Bowron A; Frost R; Powers VE; Thomas PH; Heales SJ; Steward CG
    J Inherit Metab Dis; 2013 Sep; 36(5):741-6. PubMed ID: 23109063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barth syndrome without tetralinoleoyl cardiolipin deficiency: a possible ameliorated phenotype.
    Bowron A; Honeychurch J; Williams M; Tsai-Goodman B; Clayton N; Jones L; Shortland GJ; Qureshi SA; Heales SJ; Steward CG
    J Inherit Metab Dis; 2015 Mar; 38(2):279-86. PubMed ID: 25112388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bloodspot assay using HPLC-tandem mass spectrometry for detection of Barth syndrome.
    Kulik W; van Lenthe H; Stet FS; Houtkooper RH; Kemp H; Stone JE; Steward CG; Wanders RJ; Vaz FM
    Clin Chem; 2008 Feb; 54(2):371-8. PubMed ID: 18070816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An improved functional assay in blood spot to diagnose Barth syndrome using the monolysocardiolipin/cardiolipin ratio.
    Vaz FM; van Lenthe H; Vervaart MAT; Stet FS; Klinkspoor JH; Vernon HJ; Goorden SMI; Houtkooper RH; Kulik W; Wanders RJA
    J Inherit Metab Dis; 2022 Jan; 45(1):29-37. PubMed ID: 34382226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome.
    Angelini R; Russo S; Corcelli A; Lobasso S
    J Vis Exp; 2022 Mar; (181):. PubMed ID: 35404345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome.
    Houtkooper RH; Rodenburg RJ; Thiels C; van Lenthe H; Stet F; Poll-The BT; Stone JE; Steward CG; Wanders RJ; Smeitink J; Kulik W; Vaz FM
    Anal Biochem; 2009 Apr; 387(2):230-7. PubMed ID: 19454236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution mass spectrometric analysis of cardiolipin profiles in Barth syndrome.
    Byeon SK; Ramarajan MG; Madugundu AK; Oglesbee D; Vernon HJ; Pandey A
    Mitochondrion; 2021 Sep; 60():27-32. PubMed ID: 34273557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
    Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
    J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. When silence is noise: infantile-onset Barth syndrome caused by a synonymous substitution affecting TAZ gene transcription.
    Ferri L; Dionisi-Vici C; Taurisano R; Vaz FM; Guerrini R; Morrone A
    Clin Genet; 2016 Nov; 90(5):461-465. PubMed ID: 26853223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiolipin fingerprinting of leukocytes by MALDI-TOF/MS as a screening tool for Barth syndrome.
    Angelini R; Lobasso S; Gorgoglione R; Bowron A; Steward CG; Corcelli A
    J Lipid Res; 2015 Sep; 56(9):1787-94. PubMed ID: 26144817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monolysocardiolipin in cultured fibroblasts is a sensitive and specific marker for Barth Syndrome.
    van Werkhoven MA; Thorburn DR; Gedeon AK; Pitt JJ
    J Lipid Res; 2006 Oct; 47(10):2346-51. PubMed ID: 16873891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipid abnormalities in children with Barth syndrome.
    Schlame M; Kelley RI; Feigenbaum A; Towbin JA; Heerdt PM; Schieble T; Wanders RJ; DiMauro S; Blanck TJ
    J Am Coll Cardiol; 2003 Dec; 42(11):1994-9. PubMed ID: 14662265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy.
    Zhu S; Chen Z; Zhu M; Shen Y; Leon LJ; Chi L; Spinozzi S; Tan C; Gu Y; Nguyen A; Zhou Y; Feng W; Vaz FM; Wang X; Gustafsson AB; Evans SM; Kunfu O; Fang X
    Circ Heart Fail; 2021 Jun; 14(6):e008289. PubMed ID: 34129362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative and compositional study of cardiolipin in platelets by electrospray ionization mass spectrometry: application for the identification of Barth syndrome patients.
    Valianpour F; Wanders RJ; Barth PG; Overmars H; van Gennip AH
    Clin Chem; 2002 Sep; 48(9):1390-7. PubMed ID: 12194913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrafamilial variability for novel TAZ gene mutation: Barth syndrome with dilated cardiomyopathy and heart failure in an infant and left ventricular noncompaction in his great-uncle.
    Ronvelia D; Greenwood J; Platt J; Hakim S; Zaragoza MV
    Mol Genet Metab; 2012 Nov; 107(3):428-32. PubMed ID: 23031367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barth syndrome in a female patient.
    Cosson L; Toutain A; Simard G; Kulik W; Matyas G; Guichet A; Blasco H; Maakaroun-Vermesse Z; Vaillant MC; Le Caignec C; Chantepie A; Labarthe F
    Mol Genet Metab; 2012 May; 106(1):115-20. PubMed ID: 22410210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barth syndrome.
    Clarke SL; Bowron A; Gonzalez IL; Groves SJ; Newbury-Ecob R; Clayton N; Martin RP; Tsai-Goodman B; Garratt V; Ashworth M; Bowen VM; McCurdy KR; Damin MK; Spencer CT; Toth MJ; Kelley RI; Steward CG
    Orphanet J Rare Dis; 2013 Feb; 8():23. PubMed ID: 23398819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF21 and GDF15 are elevated in Barth Syndrome and are correlated to important clinical measures.
    Liu O; Chinni BK; Manlhiot C; Vernon HJ
    Mol Genet Metab; 2023 Nov; 140(3):107676. PubMed ID: 37549445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-chain fatty acid oxidation and respiratory complex I deficiencies distinguish Barth Syndrome from idiopathic pediatric cardiomyopathy.
    Chatfield KC; Sparagna GC; Specht KS; Whitcomb LA; Omar AK; Miyamoto SD; Wolfe LM; Chicco AJ
    J Inherit Metab Dis; 2022 Jan; 45(1):111-124. PubMed ID: 34821394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anomalous peroxidase activity of cytochrome c is the primary pathogenic target in Barth syndrome.
    Kagan VE; Tyurina YY; Mikulska-Ruminska K; Damschroder D; Vieira Neto E; Lasorsa A; Kapralov AA; Tyurin VA; Amoscato AA; Samovich SN; Souryavong AB; Dar HH; Ramim A; Liang Z; Lazcano P; Ji J; Schmidtke MW; Kiselyov K; Korkmaz A; Vladimirov GK; Artyukhova MA; Rampratap P; Cole LK; Niyatie A; Baker EK; Peterson J; Hatch GM; Atkinson J; Vockley J; Kühn B; Wessells R; van der Wel PCA; Bahar I; Bayir H; Greenberg ML
    Nat Metab; 2023 Dec; 5(12):2184-2205. PubMed ID: 37996701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.